Oriyomi Alimi is a Clinical Fellow with F-Prime Capital with a focus on investments in therapeutics and medical device companies. Dr. Alimi has worked in the healthcare sector as a clinical pharmacist in the retail, health plan and hospital settings. As a graduating medical student, he spent the last year completing the Howard Hughes Medical Fellowship where he investigated the pharmacokinetics and pharmacodynamics of a humanized monoclonal antibody against a novel target.
Dr. Alimi will complete his M.D. from Yale School of Medicine May of 2020 and will start his Urology Residency at Cleveland Clinic in June 2020. He received his Pharm.D. from University of Pittsburgh.